US bank earnings – Q4 2020 look ahead
US banks lead the pack with reporting earnings for the final quarter of 2020, ones to watch between the continued 2020 earnings decline and the improved outlook into 2021.
Bank stocks had seen prices picking up momentum into end 2020 as the prospects started looking up with the vaccine breakthroughs, which also promises further resumption of economic activities down the road. The KBW Bank Index rose 34.0% in Q4 2020 while the financial sector ETF (XLF ETF) netted 22.5% gains. Ratings agencies such as Fitch had shifted their outlook for US banks to stable from negative in December, reflecting the improvement. Although, year-on-year (YoY) declines are expected to continue for Q4 2020.
|Name||Reporting Date||Period||EPS (adj.) forecast||Year-on-year (YoY) change|
|JPMorgan Chase & Co||15/1/2021||Q4 20||2.574||-2.1%|
|Citigroup Inc||15/1/2021||Q4 20||1.307||-48.1%|
|Bank of America Corp||19/1/2021||Q4 20||0.53||-30.3%|
|Goldman Sachs||19/1/2021||Q4 20||6.803||-3.2%|
|Morgan Stanley||20/1/2021||Q4 20||1.258||-4.0%|
Pandemic year-end performance
Looking back to Q4 2020 performance, pandemic effects linger for lenders with the continued deterioration of Covid-19 conditions particularly for the US where renewed movement restriction orders were noted across the nation. Concerns with regards to dropping-off of pandemic unemployment benefits had also been seen, altogether feeding to the slowdown in economic momentum for the nation.
That said, the US election arrived and brought away some of these worries with the ‘Democratic sweep’ situation seen to likewise usher in further fiscal support, injecting some confidence for businesses and the equity market alike. Specifically for trading activities, while October had been seen a continuation of Q3, the series of market news including the Covid-19 vaccine breakthroughs had enlivened the market in the last two months that should likewise support revenue for investment bank and trading arms of US banks alike. The caveat to note for the pandemic year-end performance would also be the treatment of bad loans for the year with write-down uncertainties present.
Improved fundamentals for 2021
The above said, the way to look is forward and the picture is not looking all that bad at all into 2021. Two key aspects altering the outlook for banks going into the new year will be 1) vaccine-driven recovery expectations and 2) yield curve steepening helping net interest margins. US 10-year treasury yields notably surged past 1.0% in the first week of 2021 as the prospects of further US fiscal stimulus lifted growth expectations.
According to FactSet’s December update, the estimated earnings decline for the S&P 500 index sits at -9.7% for Q4, though the consensus is for double digit percentage earnings growth in 2021. Banks had notably seen increased ‘buy’ ratings going their way to start the year, one to watch guidance from management to reaffirm this view.
US financials ETF: stock price technical analysis
While the S&P 500 index had charged on to fresh records, the KBW Bank Index and the Financial select sector ETF had remained conservatively behind compared to pre-pandemic levels. November’s revival for prices had however seen an uptrend established as prices moved along and took out a series of resistances for the XLF ETF. The $31.30 level however previous capped prices in February 2020 and may act as a strong resistance for prices. Breaking above the level may open up further upsides while immediate support is seen at the $29-30 zone.
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Act on share opportunities today
Go long or short on thousands of international stocks with CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Try a risk-free trade
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets